| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,694 |
3,143 |
$132K |
| 20611 |
|
4,260 |
2,016 |
$80K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
670 |
515 |
$73K |
| J7332 |
Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg |
884 |
337 |
$73K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
431 |
233 |
$35K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,570 |
1,338 |
$8K |
| 73562 |
|
1,166 |
717 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,483 |
1,310 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
294 |
266 |
$557.10 |
| 20553 |
|
28 |
25 |
$209.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
95 |
88 |
$2.94 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
14 |
13 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
14 |
13 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
13 |
12 |
$0.00 |